BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Feb 18, 2016; 7(2): 109-116
Published online Feb 18, 2016. doi: 10.5312/wjo.v7.i2.109
Tumors of the spine
Mert Ciftdemir, Murat Kaya, Esref Selcuk, Erol Yalniz
Mert Ciftdemir, Murat Kaya, Esref Selcuk, Erol Yalniz, Department of Orthopaedics and Traumatology, Trakya University School of Medicine, 22030 Edirne, Turkey
Author contributions: Ciftdemir M wrote the manuscript, helped in literature review and making the tables, and checked the references; Kaya M, Selcuk E and Yalniz E performed the literature review and drafted the article; all authors approved the final version of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest related to the work.
Correspondence to: Mert Ciftdemir, MD, Assistant Professor, Department of Orthopaedics and Traumatology, Trakya University School of Medicine, Balkan Yerleskesi, 22030 Edirne, Turkey. dr.mert@gmail.com
Telephone: +90-532-7653385 Fax: +90-284-2133899
Received: May 12, 2015
Peer-review started: May 18, 2015
First decision: August 19, 2015
Revised: September 20, 2015
Accepted: November 13, 2015
Article in press: November 17, 2015
Published online: February 18, 2016
Processing time: 280 Days and 7.8 Hours
Core Tip

Core tip: Primary tumors involving the spine are rare, while spinal column metastases are present in up to 70% of cancer patients. Both primary and metastatic tumors of the spine are often asymptomatic or have non-specific symptoms because in spine tumors, delayed diagnosis is not very unusual. Goal of treatment in spinal column metastases is to optimize the patient’s quality of life by providing effective pain relief and preserving or restoring neurological functions. Treatment strategy for primary tumors should be planned after both oncological and surgical staging. Because of that, biopsy is a very important step in primary tumors. Surgery in metastatic tumors are mostly palliative, aiming short-term control. Primary benign and malignant lesions mainly cause canal compromise and are treated surgically according to oncological staging and Weinstein-Boriani-Biagini classification.